Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis

Vascular Factors in Diabetes and Alzheimer's Disease

(2017) Akihiko Taguchi   JOURNAL OF ALZHEIMERS DISEASE

Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation

(2011) Sun Haeng Park et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Anti-platelet therapy: phosphodiesterase inhibitors

(2011) Paolo Gresele et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Cilostazol Reduces the Risk of Hemorrhagic Infarction After Administration of Tissue-Type Plasminogen Activator in a Murine Stroke Model

(2011) Yukiko Kasahara et al.   STROKE

Potential hippocampal region atrophy in diabetes mellitus type 2: a voxel-based morphometry VSRAD study

(2010) Kazutoshi Kamiyama et al.   JAPANESE JOURNAL OF RADIOLOGY

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial

(2010) Yukito Shinohara et al.   LANCET NEUROLOGY

A Combination Therapy of Donepezil and Cilostazol for Patients With Moderate Alzheimer Disease: Pilot Follow-Up Study

(2009) Heii Arai et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Mild cognitive impairment in the older population: Who is missed and does it matter?

(2008) Blossom C. M. Stephan et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY